Phillip A. Romanski, M.D., M.Sc.

Board Certified Board Certified

  • Obstetrics and Gynecology
  • Reproductive Endocrinology and Infertility Eligible
Patient Testimonial
Dr. Libby was just amazing. We had a long journey and she was right there with us in the trenches. She was our third fertility doctor. She thought outside the box, was willing to try new things, was open to our questions, and used her team to help us.

I went through IVF with Dr. Humm. I felt heard, comforted, and comfortable the whole way. The support staff were beyond fantastic and turned what would have been a scary experience, into something that my husband and I never felt like we were navigating alone.

Dr. Libby listened to our every concern and communicated with us when we needed it, never making us feel pushed to the side or that she was to busy to be there for us.

From the first consultation until our final appointment Dr. Doyle was empathetic, compassionate, and very easy to talk to. He reviewed my diagnosis and treatments each step of the way and changed our protocols accordingly to result in a positive and viable pregnancy.

I had an ultrasound and an HSG done at the Norfolk office. Every staff member was amazing – so gentle, comforting and supportive. I’m very grateful for that.

Dr. Banks is attentive, kind, and professional. She answered all of our questions.

Biography

Phillip A. Romanski, M.D., M.Sc., is board certified in Obstetrics and Gynecology and is board eligible in Reproductive Endocrinology and Infertility. He specializes in reproductive health and infertility as well as reproductive surgery. He serves as the Director of Research for SGF New York.

Dr. Romanski earned his medical degree from the University of Central Florida College of Medicine where he was elected to the prestigious Alpha Omega Alpha Honor Medical Society. He then began his postdoctoral training at Harvard Medical School, Brigham and Women’s Hospital/Massachusetts General Hospital where he completed his residency in Obstetrics and Gynecology. During his time in Boston, he was recognized for his dedication to education and mentorship when he was selected to serve as the Chief Education Resident for the Harvard Medical School Ob/Gyn clerkship.

From there, Dr. Romanski moved to New York City to complete his fellowship in Reproductive Endocrinology and Infertility at the Weill Cornell Medical Center/NewYork-Presbyterian Hospital. There, he not only cultivated extensive expertise in the evaluation and management of female and male infertility, third-party reproduction, and fertility preservation, but also received advanced training in the treatment of mullerian anomalies, infertile patients with a history of unsuccessful treatment, and patients with diminished ovarian reserve.

During his fellowship training, in order to enhance his ability to interpret and conduct clinical research, Dr. Romanski concurrently completed a Master of Science in Clinical and Translational Investigation at the Weill Cornell Graduate School of Medical Sciences. He has authored and contributed to over 50 peer-reviewed publications and written numerous textbook chapters, focusing on topics such as diminished ovarian reserve, age-related infertility, and reproductive surgery, among others. He was also an early leader in researching the association between Covid-19 and infertility treatment outcomes related to mental and physical health and has subsequently been invited to speak to both national and international audiences on this topic. As a distinguished researcher in the field, he is regularly invited to write editorials and review manuscripts for the leading women’s health journals including Fertility and Sterility and Obstetrics & Gynecology.

He serves as a member of the Board of Directors for the Pacific Coast Reproductive Society and is an active contributor to several other professional societies. Recently, he was recognized by the American Society for Reproductive Medicine with a first prize award for his work involving the new mullerian anomaly classification system.

Dr. Romanski provides patient care at SGF New York’s Manhattan location. In his free time, you can find Dr. Romanski exploring New York City with his wife and cat or training for his next marathon.

Read More

Education

  • Residency: Obstetrics and Gynecology, Harvard Medical School, Brigham and Women’s Hospital/Massachusetts General Hospital
  • Fellowship: Reproductive Endocrinology and Infertility, Weill Cornell Medical Center/NewYork-Presbyterian Hospital
  • Master of Science: Weill Cornell Graduate School of Medical Sciences
  • American Society for Reproductive Medicine First Prize Video Research Award
  • Obstetrics and Gynecology Excellent Peer Review – Top 10% of Peer Reviewers
  • American Association of Gynecologic Laparoscopists Golden Hysteroscope Finalist
  • American Society for Reproductive Medicine (ASRM)
  • Society for Reproductive Surgeons
  • Society for Reproductive Endocrinology and Infertility
  • American College of Obstetricians and Gynecologists
  • American Association of Gynecologic Laparoscopists
  • European Society of Human Reproduction and Embryology
  • Pacific Coast Reproductive Society
  • Romanski PA, Bortoletto P, Malmsten JE, Tan KS, Spandorfer SD. Pregnancy outcomes following oral and injectable ovulation induction in infertile women with low anti-müllerian hormone level compared to normal anti-müllerian hormone level. Fertil Steril. 2022; (In Press).
  • Romanski PA, Bortoletto P, Pfeifer SM. Cervical agenesis: surgical preservation of reproductive potential in spite of anatomic variation. Fertil Steril. 2022; (In Press).
  • Romanski PA, Bortoletto P, Pfeifer SM, Lindheim SR. An overview and video tutorial to the new interactive website for the American Society for Reproductive Medicine Müllerian Anomalies Classification 2021. Am J Obstet Gynecol. 2022; (Online ahead of print).
  • Romanski PA, Gelvin B, Bortoletto P, Rosenwaks Z, Kang HJ. Live birth outcomes among women with infertilityand anti-müllerian hormone levels of 0.3 ng/mL or lower. Obstet Gynecol. 2022; (In Press).
  • Punjani N, Romanski PA, Bortoletto P, Kang C, Spandorfer SD, Kashanian JA. The use of fresh compared to frozen ejaculated sperm has no impact on fresh embryo transfer cycle reproductive outcomes. J Assist Reprod Genet. 2022; 39(6):1409-1414.
  • Punjani N, Bortoletto P, Romanski PA, Kashanian JA, Spandorfer SD. Advancing paternal age does not negativelyimpact fresh embryo transfer cycle outcomes. Reprod Biomed Online. 2022; (Online ahead of print).
  • Bortoletto P, Romanski PA, Lindheim SR, Pfeifer SM. The American Society for Reproductive Medicine MullerianAnomalies Classification System: an updated framework with interactive tools. J Minim Invasive Gynecol. 2022; 29(7):820-822.
  • Romanski PA, Aluko A, Bortoletto P, Elias R, Rosenwaks Z. Age-specific blastocyst conversion rates in embryo cryopreservation cycles. Reprod Biomed Online. 2022; (Online ahead of print).
  • Romanski PA, Bortoletto P, Pfeifer SM. A framework approach for hysteroscopic uterine septum incision: partial and complete. Fertil Steril. 2022; 118(1):205-206.
  • Chung A, Romanski PA, Bortoletto P, Spandorfer SD. Live birth outcomes are not associated with household income and insurance disparities in infertile patients undergoing assisted reproductive technology treatment. Reprod Biomed Online. 2022; (Online ahead of print).
  • Romanski PA, Bortoletto P, Lindheim SR, Pfeifer SM. “Hear ye, hear ye, read all about it”: The new American Society for Reproductive Medicine Mullerian Anomalies Classification 2021 interactive website. J Obstet Gynaecol Can. 2022; 44(7):748-749.
  • Romanski PA, Bortoletto P, Lindheim SR. “You’ve got to know when to hold ‘em, know when to fold ‘em”: ovarian cancer risk reduction in patients with endometriosis. Fertil Steril. 2022; 117(5):946-947.
  • Bortoletto P and Romanski PA. The reproductive endocrinology and infertility fellows are who we thought they were – highly proficient. Fertil Steril. 2021; 117(1):123.
  • Romanski PA and Hariton E. Embryos with a mosaic result: the known and unknown reproductive potential. Curr Obstet Gynecol Rep. 2021; 10(4):71-76.
  • Romanski PA, Bortoletto P, Melnick A. Media regurgitation following intrauterine insemination: is the uterus half empty or half full? Fertil Steril. 2021; 116(6):1532-1533.
  • Romanski PA, Aluko A, Bortoletto P, Troiano RN, Pfeifer SM. Aqueous vaginal contrast and scheduledhematocolpos with magnetic resonance imaging to delineate complex mullerian anomalies. Fertil Steril. 2022; 117(1):221-223.
  • Bortoletto P, Romanski PA, Elias R. Surgical innovation begins at the end of your comfort zone. Fertil Steril. 2021; 116(4):1194.
  • Bortoletto P, Romanski PA, Schatz-Siemers N, Spandorfer SD. Retained Products of Conception as an Etiology for Endometritis. BJOG. 2021; 129(2):185-187.
  • Shah NJ, Romanski PA, Bortoletto P, Rosenwaks Z, Kligman I. Determining the optimal follicle size at trigger in patients undergoing ovarian stimulation with a clomiphene citrate plus gonadotropin and GnRH antagonist protocol for in vitro fertilization. Minerva Obstet Gynecol. 2022; 74(1):75-82.
  • Romanski PA, Bortoletto P, Pfeifer SM. Unilateral obstructed mullerian anomalies: a series of unusual variants of known anomalies. J Pediatr Adolesc Gynecol. 2021; 34(5):749-757.
  • Stovezky Y, Romanski PA, Bortoletto P, Spandorfer SD. Body mass index is not associated with embryo ploidy inpatients undergoing in vitro fertilization with preimplantation genetic testing. Fertil Steril. 2021; 116(2):388-395.
  • Elder S, Bortoletto P, Romanski PA, Spandorfer SD. Chronic endometritis in women with suspected retained products of conception and their reproductive outcomes. Am J Reprod Immunol. 2021; 86(2):e13410.
  • Romanski PA, Bortoletto P, Liu YL, Chung P, Rosenwaks Z. Length of follicular phase estradiol exposure >100pg/mL in the follicular phase affects pregnancy 2 outcomes in natural frozen embryo transfer cycles. Hum Reprod. 2021; 36(7):1932-1940.
  • Bortoletto P, Romanski PA, Stewart J, Rosenwaks Z, Pfeifer SM. Incidence of first trimester pregnancy loss in the infertile population during the first wave of the COVID-19 pandemic in New York City. F S Rep. 2021; 2(2):209-214.
  • Willson S, Bortoletto P, Romanski PA, Davis OK, Rosenwaks Z. Reproductive and obstetric outcomes in women of racial minorities 40 and older undergoing IVF with fresh embryo transfer. Reprod Biomed Online. 2021; 42(6):1181-1186.
  • Shapiro M, Romanski PA, Thomas A, Lanes A, Yanushpolsky E. Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study. Fertil Res and Pract. 2021; 7(1):12.
  • Romanski PA and Kang HJ. Postwash total motile sperm count and intrauterine insemination pregnancy rate: how low can you go? Fertil Steril. 2021; 115(6):1424-1425.
  • Bortoletto P, Romanski PA, Magaoay BI, Rosenwaks Z, Spandorfer SD. Time from oocyte retrieval to frozen embryo transfer in the natural cycle does not impact reproductive or neonatal outcomes. Fertil Steril. 2021; 115(5):1232-1238.
  • Bortoletto P and Romanski PA. For the next 40 years of in vitro fertilization – let’s sharpen our focus on iatrogenic harm reduction. Fertil Steril. 2021; 115(4):897.
  • Romanski PA and Kang HJ. Lessons from the tortoise and the hare. Fertil Steril. 2021; 115(3): 588- 589.
  • Romanski PA, Bortoletto P, Pfeifer SM. Creation of a novel inflatable vaginal stent for McIndoe vaginoplasty. Fertil Steril. 2021; 115(3):804-806.
  • Romanski PA, Bortoletto P, Chung A, Magaoay BI, Spandorfer SD. Reproductive and obstetric outcomes in mildlyand significantly underweight women undergoing in vitro fertilization. Reprod Biomed Online. 2021; 42(2): 366-374.
  • Romanski PA, Bortoletto P, Magaoay BI, Chung A, Spandorfer SD. Live birth outcomes in infertile patients withclass III and class IV obesity following fresh embryo transfer. J Assist Reprod Genet. 2021; 38(2):347-355.
  • Bortoletto P, Willson, S, Romanski PA, Davis OK, Rosenwaks Z. Reproductive outcomes of women aged 40 and older undergoing IVF with donor sperm. Hum Reprod. 2021; 36(1):229-235.
  • Romanski PA, Thomas AM, Patel J, Zhang D, Racowsky C. Electronic whiteboard implementation as a quality management tool optimizes IVF laboratory standardization and improves clinical outcomes. J Assist Reprod Genet. 2021; 38(1):203-210.
  • Shah NJ, Pereira N, Romanski PA, Wright C, Kligman I, Rosenwaks Z. Tubal ectopic pregnancy with undetectable initial serum β-human chorionic gonadotropin level. J Minim Invasive Gynecol. 2021; 28(1):142-145.
  • Bortoletto P, Willson, S, Romanski PA, Davis OK, Rosenwaks Z. Outcomes and characteristics of patients whoundergo intrauterine insemination immediately following failed oocyte retrieval. F S Rep. 2020; 1(3):239-242.
  • Deshpande M, Romanski PA, Rosenwaks Z, Gerhardt J. Gynecological cancers caused by deficient mismatch repair and microsatellite instability. Cancers (Basel). 2020; 12(11):3319.
  • Romanski PA, Bartz D, Pelletier A, Johnson NR. The “invisible student”: Neglect as a form of medical student mistreatment, a call to action. J Surg Educ. 2020; 77(6):1327-1330.
  • Romanski PA, Bortoletto P, Rosenwaks Z, Schattman GL. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve. Hum Reprod. 2020; 35(7):1630-1636.
  • Bakkensen JB, Brady P, Carusi D, Romanski P, Thomas AM, Racowsky C. Association between blastocystmorphology and pregnancy and perinatal outcomes after fresh and cryopreserved single embryo transfer. J Assist Reprod Genet. 2019; 36(11):2315-2324.
  • Romanski PA, James KE, Sabatini ME. Women’s health providers’ perspectives on preimplantation genetic testing. Reprod Biomed Online. 2019; 39(3):530-537.
  • Romanski PA, Brady PC, Farland LV, Thomas AM, Hornstein MD. The effect of endometriosis on the antimullerian hormone level in the infertile population. J Assist Reprod Genet. 2019; 36(6):1179-1184.
  • Romanski PA, Farland LV, Tsen LC, Ginsburg ES, Lewis EI. Effect of class III and class IV obesity on oocyte retrieval complications and outcomes. Fertil Steril. 2019; 111(2):294-301.e1.
  • Romanski PA, Goldman RH, Farland LV, Srouji SS, Racowsky C. The association between quality of supernumerary embryos in a cohort and implantation potential of the transferred blastocyst. J Assist Reprod Genet. 2018; 35(9):1651-1656.
  • Romanski PA, Carusi DA, Farland LV, Missmer SA, Kaser DJ, Walsh BW, Racowsky C, Brady PC. Perinatal and peripartum outcomes in vanishing twin pregnancies achieved by in vitro fertilization. Obstet Gynecol. 2018;131(6):1011-1020.
  • Romanski PA, Melamed A, Elias KM, Stanic AK, Anchan RM. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment. J Assist Reprod Genet. 2017; 34(5):627-631.
  • Romanski PA, Stanic AK. Practical approach to the PCOS patient. Curr Obstet Gynecol Rep. 2017; 6:11-20.
  • Dixon CL, Bhullar A, Romanski PA, Carlan, S. Effect of a ‘hard stop’ on elective labor inductions and cesarean delivery rate. J Reprod Med. 2016; 61(9-10):411-415.
  • Bortoletto P, Applegarth L, Josephs L, Witzke J, Romanski PA, Schattman GL, Grill E. Psychosocial response ofinfertile patients to COVID-19-related delays in care at the epicenter of the global pandemic. Minerva Obstet Gynecol. 2021 [Online ahead of print].

Q&A

As a reproductive endocrinologist, I have the great privilege of working with patients as they are planning their reproductive future. I enjoy learning about my patients’ reproductive journey and how I can best help them to accomplish their family-building goals. Together, we will discuss evidence-based options that incorporate patient preferences in order to create a treatment plan that is both safe and specific to each individual patient. We will continue to work together until your goals have successfully been accomplished.

I have a great passion for women’s health and find it very rewarding to be able to walk my patients through the exceptional and complex biologic process that is reproductive endocrinology. As a reproductive endocrinologist, I am able to provide all aspects of reproductive care for my patients including ultrasonography, medical treatments, and surgical management when needed. Having this full armamentarium that I can offer allows me to provide the best treatment for my patients in an efficient manner that simplifies the patient experience and optimizes treatment outcomes.

I am incredibly proud to be a member of Shady Grove Fertility because we have such a supportive and caring team. Fertility treatments can be a physical and emotional challenge for patients, and I know that from the moment our patients walk through the door, their interactions with our medical assistants, nurses, physicians, and office staff will be encouraging, supportive, and positive. At Shady Grove Fertility, our patient-centered care approach helps to ensure our patients’ needs are surpassed, which contributes to the successful outcomes experienced by our patients.  

I am inspired by each and every one of my patients. Each one is on their own unique journey, and it takes strength and fortitude to pursue any type of fertility treatment. Life, relationships, and careers can sometimes create barriers to family building and seeking fertility treatment, and I am inspired by my patients who have the resolve to prioritize their health and desire to grow their family or preserve their fertility.

It is important to remember that each patient’s experience is unique. Patients can struggle emotionally, physically, or financially, and sometimes in more ways than one. It is my job to identify when a patient may be having a difficult time. Through frequent communication and active listening, I work to make sure my patients have the resources they need and to ease their concerns. This can sometimes require creative solutions, which I embrace. My team and I want our patients to always remember that we are here to support them in any way we can. 

I am inspired by the strong women in my family. My mother is my ultimate supporter and, as a school teacher, she taught me how to meet others where they are and to be mindful that everyone has different needs and resources. My sister always set the example for me to follow, and I am inspired by her drive to accomplish her goals and her inherent ability to put others’ needs first. I strive to be like these women in both my professional and personal life.

I am easy to talk to and have a calm demeanor. Professionally, I value being honest with my patients while providing compassionate and patient-centered care.

I enjoy traveling when I can, so I have a list of places I hope to visit one day. I am just as likely to be camping in the remote wilderness as I am exploring urban cities. Through traveling, I have learned that the journey can be just as memorable as the destination, and this is something I try to cherish and appreciate.

My biggest hobby is running. I am a marathoner and often spend my early mornings running in Central Park or around the city. For me, running brings a great community of people actively enjoying the outdoors. I enjoy setting goals for myself and others and pushing to achieve them. I particularly enjoy how accessible the sport is because all you need is a pair of shoes. You can run nearly anywhere anytime, and it is one of my favorite ways to explore New York City or really any city to which I travel.

Public events & seminars

View All Events